Isoba vet 100 % w/w Norge - norsk - Statens legemiddelverk

isoba vet 100 % w/w

intervet international bv - 5831 an - isofluran - væske til inhalasjonsdamp - 100 % w/w

IsoFlo vet 100 % w/w Norge - norsk - Statens legemiddelverk

isoflo vet 100 % w/w

zoetis finland oy - isofluran - væske til inhalasjonsdamp - 100 % w/w

Vetflurane 1000 mg/ g Norge - norsk - Statens legemiddelverk

vetflurane 1000 mg/ g

virbac s.a. - isofluran - væske til inhalasjonsdamp - 1000 mg/ g

Isocare Vet 1000 mg/ g Norge - norsk - Statens legemiddelverk

isocare vet 1000 mg/ g

ecuphar nv - isofluran - væske til inhalasjonsdamp - 1000 mg/ g

Xeden vet 150 mg Norge - norsk - Statens legemiddelverk

xeden vet 150 mg

ceva santé animale - enrofloksacin - tablett - 150 mg

Xeden vet 15 mg Norge - norsk - Statens legemiddelverk

xeden vet 15 mg

ceva santé animale - enrofloksacin - tablett - 15 mg

Xeden vet 50 mg Norge - norsk - Statens legemiddelverk

xeden vet 50 mg

ceva santé animale - enrofloksacin - tablett - 50 mg

Okedi Den europeiske union - norsk - EMA (European Medicines Agency)

okedi

laboratorios farmacéuticos rovi, s.a. - risperidone - schizofreni - psykoleptiske - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.

Spikevax (previously COVID-19 Vaccine Moderna) Den europeiske union - norsk - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaksiner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Fuxien vet 1000 mg/ g Norge - norsk - Statens legemiddelverk

fuxien vet 1000 mg/ g

vetpharma animal health, s.l. - isofluran - væske til inhalasjonsdamp - 1000 mg/ g